Integrated Diagnostics Holdings PLC logo

Integrated Diagnostics Holdings PLC (8I8)

Market Open
5 Jun, 20:00
XMUN XMUN
0. 49
-0.01
-2.5743%
11.86B Market Cap
14.8 P/E Ratio
0.2% Div Yield
0 Volume
0 Eps
0.51
Previous Close
Add Transaction
Day Range
0.49 0.49
Year Range
0.3 0.66
Want to track 8I8 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

8I8 trading today lower at €0.49, a decrease of -2.5743% from yesterday's close, completing a monthly decrease of -2.5743% or -€0.01. Over the past 12 months, 8I8 stock lost -16.6102%.
8I8 pays dividends to its shareholders, with the most recent payment made on Oct 03, 2025. The next announced payment will be in In 1 week on Jun 22, 2026 for a total of €0.0085.
The last earnings report, released on Apr 16, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Integrated Diagnostics Holdings PLC has completed 1 stock splits, with the recent split occurring on Dec 24, 2020.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on LSE (USD).

8I8 Chart

People also search for

SQU
Vinci SA
127
+0.7537%

Integrated Diagnostics Holdings PLC (8I8) FAQ

What is the stock price today?

The current price is €0.49.

On which exchange is it traded?

Integrated Diagnostics Holdings PLC is listed on XMUN.

What is its stock symbol?

The ticker symbol is 8I8.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.2%.

What is its market cap?

As of today, the market cap is 11.86B.

Has Integrated Diagnostics Holdings PLC ever had a stock split?

Integrated Diagnostics Holdings PLC had 1 splits and the recent split was on Dec 24, 2020.

Integrated Diagnostics Holdings PLC Profile

Professional Services Industry
Industrials Sector
Hend El Sherbini CEO
XMUN Exchange
JE00BLKGSR75 ISIN
JE Country
6,309 Employees
28 May 2026 Last Dividend
24 Dec 2020 Last Split
- IPO Date

Overview

Integrated Diagnostics Holdings plc, established in 1979 and headquartered in Saint Helier, Jersey, stands as a prominent consumer healthcare entity focusing on the provision of an extensive array of medical diagnostic services to its patients. The company has forged a significant presence across Egypt, Sudan, Jordan, Nigeria, and the Kingdom of Saudi Arabia, offering a comprehensive suite of diagnostic solutions tailored to meet a diverse range of patient needs. With its expert capabilities in various medical diagnostics domains, Integrated Diagnostics Holdings plc plays a crucial role in enhancing healthcare delivery in the regions it operates.

Products and Services

The company's offerings encompass a wide spectrum of diagnostic pathology tests and radiology services, each characterized by a commitment to quality, precision, and patient-centric care:

  • Diagnostic Pathology Tests: Integrated Diagnostics Holdings plc delivers around 3,000 different diagnostic pathology tests covering a broad range of fields. These include:
    • Immunology: Studies related to the immune system and its defects.
    • Microbiology: Involves analysis of microorganisms, including bacteria and viruses.
    • Haematology: Focuses on diseases affecting the blood and its components.
    • Endocrinology: Tests related to hormonal imbalances and disorders.
    • Clinical Chemistry: Deals with the chemical analysis of bodily fluids for diagnostics.
    • Molecular Biology: Involves examining genetic material for genetic diseases and conditions.
    • Parasitology: The study and detection of parasitic infections.
    • Histopathology: Examines tissues to diagnose diseases like cancer.
    • Genetics: Specialized tests to detect hereditary diseases and conditions.
  • Radiology Services: Alongside pathology tests, the company also provides an advanced range of radiology services to assist in the accurate diagnosis and management of various conditions. These services include:
    • Positron Emission Tomography – Computed Tomography (PET-CT): Combines PET and CT technologies for high-precision disease diagnosis.
    • Magnetic Resonance Imaging (MRI): Utilizes magnetic fields and radio waves to produce detailed images of organs and tissues.
    • Computed Tomography (CT): Employs computer-processed combinations of many X-ray measurements taken from different angles to produce cross-sectional images.
    • Mammography: Specialized imaging using X-rays for early detection of breast cancer.
    • Ultrasound: Uses high-frequency sound waves to create images of organs and structures inside the body.
    • X-Ray: A quick and painless test that produces images of the structures inside the body, particularly the bones.
    • Electromyography (EMG): Measures muscle response or electrical activity in response to a nerve’s stimulation of the muscle.
    • Electroencephalography (EEG): Detects abnormalities in the brain waves or electrical activity of the brain.
    • Electrocardiogram (ECG): Records the electrical signals in the heart to detect heart problems and monitor the heart's status.
    • Additionally, the company operates cath lab facilities to support a range of cardiovascular procedures, furthering its capability to offer comprehensive patient care.

Contact Information

Address: 12 Castle Street
Phone: 44 15 3484 7000